Wearable Medical Devices Market size is set to Grow at a Remarkable Pace by 2032

Wearable Medical Devices Market is anticipated to reach US$ 73.48 billion by 2032 at a 28.1% CAGR. The wearable medical device industry is predicted to rise due to a growing population and an increase in the number of chronic diseases. As a result of regulatory initiatives, healthcare sector expansion, and an increase in the number of patients, companies in the healthcare industry and product approvals have grown rapidly.

With 5G and AI, the most likely diagnosis and treatments for a patient can be found. AI can also assist healthcare providers in predicting which patients are likely to experience difficulties following surgery, allowing them to take precautionary measures. Real-time learning with massive amounts of data often demands high availability and throughput networks.

With the introduction of 5G networks, healthcare professionals will be able to leverage AI apps to give immediate, high-quality care to patients all around the world. As a result, cutting-edge innovations like as artificial intelligence and fifth-generation wireless networks are expected to have a substantial impact on wearable medical equipment.

Key Takeaways

  • The wearable medical devices industry is expected to be worth $324.65 billion by 2032.
  • Because of increased incidence of cardiovascular disease, diabetes, and cancer, North America will contribute 38.1% of worldwide revenue in 2020.
  • During COVID-19, market growth is expected as a result of growing adoption of wearable devices for health management.
  • The wearable medical device market is being driven by the rising prevalence of target diseases due to an ageing population and the need to reduce healthcare spending.

Competitive Landscape

  • Medtronic plc
  • Siemens AG
  • Fitbit Inc.
  • Bayer AG
  • Panasonic Corporation
  • Animas Corporation - Johnson and Johnson
  • Smiths Medical - A Smiths Group Company
  • Koninklijke Philips N.V.
  • Owlet Baby Care
  • OMRON Corporation
  • Hoffmann-La Roche Ltd and Rest Devices Inc

Read More@ https://www.futuremarketinsights.com/reports/wearable-medical-devices-market

Wearable Medical Devices Market By Segmentation

By Product:

  • Wearable Monitoring and Diagnostic Devices
  • Fetal and Obstetric Devices
    • Wearable Fetal Monitors
    • Infant Motion Sensing Monitors
  • Continuous Glucose Monitoring Devices
  • Cardiac Monitoring Devices
    • Wearable Heart Rate Monitors
    • Wearable Pulse Oximeters
    • Wearable Blood Pressure Monitors
  • Wearable Therapeutic Medical Device
  • Hearing Aid
  • Insulin Pump
  • Respiratory Therapy Devices
    • Sleep Apnea Devices
    • Non-invasive Ventilation
  • Health and Fitness Devices

By Application:

  • Patient Monitoring
  • Home Healthcare
  • Health and Fitness

By Distribution Channel:

  • Hospital Pharmacies
  • Clinics
  • Online Channels
  • Hypermarkets

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more